The NC1 domain of type XIX collagen inhibits melanoma cell migration

European Journal of Dermatology

Volumn 20, Issue 6, 2010, Pages 712-718

  Toubal, Aida ^a   Ramont, Laurent ^a,b   Terryn, Christine ^a   Brassart Pasco, Sylvie ^a   Patigny, Dominique ^a   Sapi, Janos ^a   Monboisse, Jean Claude ^a,b   Maquart, François Xavier ^a,b  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Angiogenesis; Basement membranes; Cell migration; Collagen XIX; Matrikines; Melanoma; NC1 domains

Indexed keywords

ASPARAGINYLPROLYLGLUTAMYLASPARTYLCYSTEINYLLEUCYLTYROSYLPROLYLVALYLSERYLHISTIDYLALANYLHISTIDYLGLUTAMINYLARGINYLTHREONYLGLYCYLGLYCYLASPARAGINE; COLLAGEN; COLLAGEN 19; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN DOMAIN;

ANIMALS; BASEMENT MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; EXTRACELLULAR MATRIX; MELANOMA; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; SKIN NEOPLASMS;

EID: 78649812940     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1070     Document Type: Article

References (38)

1. Yoshioka H, Zang H, Ramirez F, et al. Synteny between the loci from a novel FACIT-like collagen locus (D6S228E) and α1(XIX) collagen (COL19A1) on 6q12-14 in human. Genomics 1992; 13: 884-6.
2. Myers JC, Sun MJ, D'Ippolito JA, Jabs EJ, Neilson EG, Dion AS. Human cDNA clones transcribed from an unusually high-molecular weight encode a new collagen chain. Gene 1993; 123: 211-7.
3. Inoguchi K, Yoshioka H, Khaleduzzaman M, Ninomiya Y. The mRNA for α1(XIX) collagen chain, a new member of FACITs, contains a long unusual 3′ untranslated region and displays many unique splicing variants. J Biochem 1995; 117: 137-48.
4. Ricard-Blum S, Dublet B, Van der Rest M. Unconventional collagens: types VI, VII, VIII, IX, X, XII, XIV and XIX. Protein profile. Oxford, England: Oxford University Press, 2000.
5. Myers JC, Li D, Bageris A, Abraham V, Dion AS, Amenta P. Biochemical and immunohistochemical characterization of human type XIX defines a novel class of basement membrane zone collagens. Am J Pathol 1997; 151: 1729-40. (Pubitemid 27527935)
6. Sumiyoshi H, Inoguchi K, Khaleduzzaman M, Ninomiya Y, Yoshioka H. Ubiquitous expression of the α1(XIX) collagen gene (Col19a1) during mouse embryogenesis becomes restricted to a few tissues in the adult organism. J Biol Chem 1997; 272: 17104-11. (Pubitemid 27289819)
7. Myers JC, Li D, Amenta PS, Clark CC, Nagaswani C, Weisel JW. Type XIX collagen purified from human umbilical cord is characterized by multiple sharp kinks delineating collagenous subdomains and by intermolecular aggregates via globular, disulfide-linked, and heparin-binding amino termini. J Biol Chem 2003; 278: 32047-57. (Pubitemid 37048393)
8. Myers JC, Yang H, D'Ippolito JA, Presente A, Miller MK, Dion AS. The triple-helical region of human type XIX collagen consists of multiple collagenous subdomains and exhibits limited sequence homology to α1(XVI). J Biol Chem 1994; 269: 18549-57.
9. Boudko SP, Engel T, Bächinger HP. Trimerization and triple helix stabilization of the collagen XIX NC2 domain. J Biol Chem 2008; 283: 34345-51.
10. Myers JC, Li D, Rubinstein NA, Clark CC. Up-regulation of type XIX collagen in rhabdomyosarcoma cells accompanies myogenic differentiation. Exp Cell Res 1999; 253: 587-98. (Pubitemid 30003120)
11. Sumiyoshi H, Laub F, Yoshioka H, Ramirez F. Embryonic expression of type XIX collagen is transient and confined to muscle cells. Dev Dyn 2001; 220: 155-62. (Pubitemid 32107816)
12. Sumiyoshi H, Mor N, Lee SY, et al. Eosophageal muscle physiology and morphogenesis require assembly of a collagen XIX-rich basement membrane zone. J Cell Biol 2004; 166: 591-600. (Pubitemid 39097178)
13. Su J, Gorse K, Ramirez F. Collagen XIX is expressed by interneurons and contributes to the formation of hippocampal synapses. J Comp Neurol 2010; 518: 229-53.
14. Amenta PS, Hadad S, Lee MI, Barnard N, Li D, Myers JC. Loss of type XV and XIX collagens precedes basement membrane invasion in ductal carcinoma of the female breast. J Pathol 2003; 199: 298-308. (Pubitemid 36266852)
15. Maquart FX, Pasco S, Ramont L, Hornebeck W, Monboisse JC. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity: implication in tumor invasion. Crit Rev Oncol Hematol 2004; 49: 199-202. (Pubitemid 38251352)
16. Ramont L, Brassart-Pasco S, Thevenard J, et al. The NC1 domain of type XIX collagen inhibits in vivo melanoma growth. Mol Cancer Ther 2007; 6: 506-14. (Pubitemid 46332452)
17. Bouifraden S, Drouot C, El Hadrami M, et al. Some of the amino acid chemistry going on in the laboratory of amino acids, peptides and proteins. Amino Acids 1999: 345-79.
18. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996; 19: 1518-20. (Pubitemid 26403266)
19. Zahm JM, Kaplan H, Hérard AL, et al. Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. Cell Motil Cytoskel 1997; 37: 33-43. (Pubitemid 27199682)
20. Wald M, Olejar T, Sebkova M, Zadinova M, Boubelik M, Pouckova P. Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57B16 mice with syngenic melanoma B16. Cancer Chemother Pharmacol 2001; 47: 16-22.
21. Fritsch P, Burgdorf W, Murphy G, Ring J. Skin diseases in Europe. Eur J Dermatol 2006; 16: 209-18.
22. Friedl P, Wolf K. Tumour cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-637.
23. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010; 188: 11-9.
24. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007; 17: 107-17. (Pubitemid 46341826)
25. Rowe RG, Weiss SJ. Breaching the basement membrane: Who, When and How? Trends Cell Biol 2008; 18: 560-74.
26. Pasco S, Ramont L, Maquart FX, Monboisse JC. Control of melanoma progression by various matrikines from basement membrane macromolecules. Crit Rev Oncol Hematol 2004; 49: 221-33. (Pubitemid 38251354)
27. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010; 188: 11-9.
28. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84: 359-69.
29. Spack J, Adams RB, Rovin JD, Bissonette EA, Stoker CE, Parsons JT. Alteration in the Focal Adhesion Kinase/Src signal transduction pathway correlates with increased migratory capacity of prostate carcinoma cells. Oncogene 2001; 20: 1152-63.
30. Nobes CD, Hall A. Rho-GTPases control polarity, protrusion and adhesion during cell movement. J Cell Biol 1999; 144: 1235-44. (Pubitemid 29157301)
31. Sanz-Moreno V, Marshall CJ. Rho-GTPase signaling drives melanoma cell plasticity. Cell Cycle 2009; 8: 1484-7.
32. Bertagnolo V, Benedusi M, Brugnoli F, et al. Phospholipase-C-beta-2 promotes mitosis and migration of human breast cancer-derived cells. Carcinogenesis 2007; 28: 1638-45. (Pubitemid 47289024)
33. Klemke RL, Cai S, Giannini AL, Gallagher PJ, De Lanerolle P, Cheresh DA. Regulation of cell motility by mitogen activated protein kinase. J Cell Biol 1997; 137: 481-92. (Pubitemid 27181299)
34. Ohnishi Y, Tajima S, Ishibashi A. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells. Eur J Dermatol 2001; 11: 420-3. (Pubitemid 32801337)
35. Mekkawy AH, Morris DL, Pourgholami MH. Urokinase plasminogen activator system as a potential target for cancer therapy. Future Oncol 2009; 9: 1487-99.
36. Shahan TA, Ziaic Z, Pasco S, et al. Identification of CD47/integrin-associated protein and alpha(v)beta-3 as two receptors for the α3(IV) chain of type IV collagen on tumor cells. Cancer Res 1999; 59: 4584-90.
37. Pasco S, Monboisse JC, Kieffer N. The alpha 3 (IV) 185-206 peptide from non collagenous domain 1 of type IV collagen interacts with a novel binding site on the beta-3 suburit of integrin alpha-v beta-3 and stimulates focal adhesion kinase and phosphatidyl-inositol 3 kinase phosphorylation. J Biol Chem 2000; 275: 32299-3007.
38. Kyrgidis A, Tzellos TG, Triaridis S. Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications. J Carcinog 2010; 9: 3.